Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biotechnology Business
Cerus Appoints Carol M. Moore as Vice President, Regulatory Affairs and Quality
April 19th, 2008
Cerus Corporation (NASDAQ: CERS) announced that Carol M. Moore has been appointed vice president, regulatory affairs and quality. In that position, Ms. Moore will be responsible for implementing global strategies for registration and regulatory compliance and with maintaining ISO quality standards related to the INTERCEPT Blood System. Prior to joining Cerus, Ms. Moore was vice president, worldwide regulatory affairs for Bayer Corporation. In that position, she held primary responsibility for interactions with health authorities worldwide involving the registration and regulatory compliance of Bayer's biological and biotech products. She was involved at Bayer in health...
Source: Law & Health Weekly (2008-04-19)
|
